Literature DB >> 16544257

Complexity of Plasmodium falciparum infections and antimalarial drug efficacy at 7 sites in Uganda.

Sulggi A Lee1, Adoke Yeka, Samuel L Nsobya, Christian Dokomajilar, Philip J Rosenthal, Ambrose Talisuna, Grant Dorsey.   

Abstract

Malaria infections in Africa frequently include multiple parasite strains. We examined the relationship between the number of infecting Plasmodium falciparum strains and the responses to 3 different combination therapies in 3072 patients with uncomplicated malaria at 7 sites in Uganda. Patients infected with > or =3 strains had almost 3 times the odds of treatment failure (odds ratio, 2.93 [95% confidence interval, 2.51-3.43]; P<.001), compared with those infected with 1 or 2 strains. Our data suggest that efforts to reduce the complexity of infection in highly endemic areas through the use of intermittent presumptive therapy, improved case management, and reduction in transmission intensity may improve the efficacy of antimalarial therapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16544257     DOI: 10.1086/501473

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  Estimating true antimalarial efficacy by heteroduplex tracking assay in patients with complex Plasmodium falciparum infections.

Authors:  Jesse J Kwiek; Alisa P Alker; Emily C Wenink; Marjorie Chaponda; Linda V Kalilani; Steven R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

2.  Higher Complexity of Infection and Genetic Diversity of Plasmodium vivax Than Plasmodium falciparum Across All Malaria Transmission Zones of Papua New Guinea.

Authors:  Abebe A Fola; G L Abby Harrison; Mita Hapsari Hazairin; Céline Barnadas; Manuel W Hetzel; Jonah Iga; Peter M Siba; Ivo Mueller; Alyssa E Barry
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

3.  Multiplicity of Plasmodium falciparum infection predicts antimalarial treatment outcome in Ugandan children.

Authors:  Daniel J Kyabayinze; Charles Karamagi; Moses Kiggundu; Moses R Kamya; Fred Wabwire-Mangen; Fred Kironde; Ambrose Talisuna
Journal:  Afr Health Sci       Date:  2008-12       Impact factor: 0.927

4.  Genetic structure of Plasmodium vivax and Plasmodium falciparum in the Bannu district of Pakistan.

Authors:  Lubna Khatoon; Frederick N Baliraine; Mariangela Bonizzoni; Salman A Malik; Guiyun Yan
Journal:  Malar J       Date:  2010-04-23       Impact factor: 2.979

5.  Mixed infections and In Vivo evolution in the human fungal pathogen Cryptococcus neoformans.

Authors:  Marie Desnos-Ollivier; Sweta Patel; Adam R Spaulding; Caroline Charlier; Dea Garcia-Hermoso; Kirsten Nielsen; Françoise Dromer
Journal:  MBio       Date:  2010-05-18       Impact factor: 7.867

6.  A cohort study of Plasmodium falciparum infection dynamics in Western Kenya Highlands.

Authors:  Frederick N Baliraine; Yaw A Afrane; Dolphine A Amenya; Mariangela Bonizzoni; Anne M Vardo-Zalik; David M Menge; Andrew K Githeko; Guiyun Yan
Journal:  BMC Infect Dis       Date:  2010-09-24       Impact factor: 3.090

7.  Effects of Plasmodium falciparum mixed infections on in vitro antimalarial drug tests and genotyping.

Authors:  Shengfa Liu; Jianbing Mu; Hongying Jiang; Xin-zhuan Su
Journal:  Am J Trop Med Hyg       Date:  2008-08       Impact factor: 2.345

Review 8.  Large-scale genotyping and genetic mapping in Plasmodium parasites.

Authors:  Xin-Zhuan Su; Hongying Jiang; Ming Yi; Jianbing Mu; Robert M Stephens
Journal:  Korean J Parasitol       Date:  2009-05-26       Impact factor: 1.341

Review 9.  Molecular epidemiology of malaria.

Authors:  David J Conway
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

10.  Effects of point mutations in Plasmodium falciparum dihydrofolate reductase and dihydropterate synthase genes on clinical outcomes and in vitro susceptibility to sulfadoxine and pyrimethamine.

Authors:  David J Bacon; Doug Tang; Carola Salas; Norma Roncal; Carmen Lucas; Lucia Gerena; Lorena Tapia; A Alejandro Llanos-Cuentas; Coralith Garcia; Lelv Solari; Dennis Kyle; Alan J Magill
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.